Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

A randomised, double blind, placebo controlled, crossover study of digoxin withdrawal and reintroduction was carried out over two periods of eight weeks each after long term treatment. Forty four patients with stable heart failure in sinus rhythm and plasma digoxin concentrations over 0.8 ng/ml were...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Pugh, SE, White, N, Aronson, J, Grahame-Smith, D, Bloomfield, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	BMJ Publishing Group 1989

Gelijkaardige items

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
door: Pugh, S, et al.
Gepubliceerd in: (1982)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
door: Aronson, J, et al.
Gepubliceerd in: (1978)

In vivo cation transport during short-term and long-term digoxin therapy.
door: Boon, N, et al.
Gepubliceerd in: (1986)

Digoxin in advanced heart failure patients: A question of rhythm
door: Elisabete Jorge, et al.
Gepubliceerd in: (2013-04-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and haemodynamic performance of an isolated, perfused, working guinea-pig heart.
door: Zannad, F, et al.
Gepubliceerd in: (1982)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
door: Ford, A, et al.
Gepubliceerd in: (1979)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
door: Aronson, J, et al.
Gepubliceerd in: (1977)

Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
door: Ford, A, et al.
Gepubliceerd in: (1979)

Digoxin revisited.
door: Aronson, J
Gepubliceerd in: (1998)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
door: Ford, A, et al.
Gepubliceerd in: (1979)

Interaction of digoxin with quinine.
door: Aronson, J, et al.
Gepubliceerd in: (1981)

A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride.
door: Boon, N, et al.
Gepubliceerd in: (1984)

Clinical pharmacokinetics of digoxin 1980.
door: Aronson, J
Gepubliceerd in: (1980)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
door: Aronson, J, et al.
Gepubliceerd in: (1983)

Indications for the measurement of plasma digoxin concentrations.
door: Aronson, J
Gepubliceerd in: (1983)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
door: Aronson, J, et al.
Gepubliceerd in: (1977)

ABC of monitoring drug therapy. Digoxin.
door: Aronson, J, et al.
Gepubliceerd in: (1992)

Digoxin and Heart Failure: Are We Clear Yet?
door: Amit Gupta, et al.
Gepubliceerd in: (2017-04-01)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
door: Boon, N, et al.
Gepubliceerd in: (1984)

A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.
door: Wood, A, et al.
Gepubliceerd in: (1989)

Monitoring digoxin therapy: III. How useful are the nomograms?
door: Aronson, J
Gepubliceerd in: (1978)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
door: Aronson, J, et al.
Gepubliceerd in: (1982)

The effect of digoxin on renal function in patients with heart failure
door: Parin Shah, et al.
Gepubliceerd in: (2021-10-01)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
door: Aronson, J, et al.
Gepubliceerd in: (1980)

Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.
door: Jo-Jo Hai, et al.
Gepubliceerd in: (2016-01-01)

Risk of stroke in patients with heart failure and sinus rhythm: data from the Swedish Heart Failure Registry
door: Clara Hjalmarsson, et al.
Gepubliceerd in: (2021-02-01)

Clinical pharmacology. Adverse drug interactions.
door: Aronson, J, et al.
Gepubliceerd in: (1981)

THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART
door: Zannad, F, et al.
Gepubliceerd in: (1982)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and performance of an isolated, perfused working guinea-pig heart
door: Zannad, F, et al.
Gepubliceerd in: (1982)

Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
door: Jain Shreepal, et al.
Gepubliceerd in: (2009-01-01)

Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
door: Jingmin Zhou, et al.
Gepubliceerd in: (2020-02-01)

Left Atrial Strain to Predict Stroke in Patients With Acute Heart Failure and Sinus Rhythm
door: Jae‐Hyeong Park, et al.
Gepubliceerd in: (2021-07-01)

Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm
door: Francesc Formiga, et al.
Gepubliceerd in: (2022-10-01)

Echocardiographic predictors of severe heart failure symptoms in hypertrophic cardiomyopathy patients with sinus rhythm
door: Degertekin Muzaffer, et al.
Gepubliceerd in: (2008-02-01)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
door: Sophia Sheikh, et al.
Gepubliceerd in: (2024-06-01)

Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
door: Ioanna Koniari, et al.
Gepubliceerd in: (2022-05-01)

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
door: Kevin Y. Chang, et al.
Gepubliceerd in: (2023-03-01)

Haemodynamic determinants of quality of life in chronic heart failure
door: Serlie Fatrin, et al.
Gepubliceerd in: (2022-09-01)

Haemodynamic effects of sacubitril/valsartan in advanced heart failure
door: Piero Gentile, et al.
Gepubliceerd in: (2022-04-01)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
door: M Yurdakök, et al.
Gepubliceerd in: (1989-10-01)